A Study of LY3031207 in Healthy Subjects

NCT01449630 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LY3031207
DRUG: Placebo
DRUG: Celecoxib

Sponsor

Eli Lilly and Company